Proxy Votes Now

Home › Funds › Guardian Variable Products Trust › Guardian Small-Mid Cap Core VIP Fund

Guardian Small-Mid Cap Core VIP Fund proxy voting record 2025-2026

Fund family: Guardian Variable Products Trust · Filed by Guardian Variable Products Trust (CIK 1668512) · SEC series S000068792

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 718 with, 4 against, 12 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 3 FOR, 2 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Guardian Variable Products Trust as a whole

The same two figures as Guardian Variable Products Trust’s manager page (18,796 ballot items across 19 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsGuardian Variable Products TrustItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)93.4%71195.0%16,463
Backed environmental and social shareholder proposals at US companiesn/a08.5%505

Where this fund voted differently from most Guardian Variable Products Trust funds

Each ballot item this fund voted is set against the votes of the other Guardian Variable Products Trust funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Guardian Variable Products Trust funds on 2 items (3.8% of the 52 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Guardian Variable Products Trust fundsMgmtResult
UNITED THERAPEUTICS CORPORATION2026-06-26Approval of the United Therapeutics Corporation 2026 Stock Incentive Plan.AgainstFOR — 3 of 3 Guardian Variable Products Trust fundsAgainstPassed (calculated), 72.0% support
OKTA, INC.2026-06-18To approve, on an advisory non-binding basis, the compensation of our named executive officers.AgainstFOR — 2 of 3 Guardian Variable Products Trust fundsAgainstApproved, 75.9% support

Download all 2 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 95.4% of this fund’s 734 such votes could be given a sector; the other 34 (4.6%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance17310.6%
Industrials14610.7%
Health Care12410.8%
Consumer Discretionary12200.0%
Technology4600.0%
Real Estate2600.0%
Utilities2400.0%
Basic Materials1700.0%
Energy1700.0%
Telecommunications500.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections5210
Audit-related840
Say-on-Pay840
Compensation181
Corporate Governance162
Capital Structure90
Other40
Shareholder Rights and Defenses31
Extraordinary Transactions20

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
OKTA, INC.June 18, 2026$6M50
BIO-RAD LABORATORIES, INC.April 21, 2026$5M61
HAEMONETICS CORPORATIONJuly 24, 2025$5M110
ON SEMICONDUCTOR CORPORATIONMay 14, 2026$5M100
ROKU, INC.June 11, 2026$5M50
AZENTA, INC.January 28, 2026$5M130
BRUKER CORPORATIONMay 21, 2026$4M50
ALLIENT INC.May 6, 2026$4M80

Notable votes against management

MeetingCompanyProposalFundMgmt
April 21, 2026BIO-RAD LABORATORIES, INC.Stockholder proposal regarding dual class capital structure. Shareholder proposalForAgainst
April 16, 2026HUMANA INC.The stockholder proposal requesting shareholder approval requirement for excessive golden parachutes, if properly presented at the meeting. Shareholder proposalForAgainst
April 30, 2026CROWN HOLDINGS, INC.Consideration of a Shareholder proposal regarding Shareholder right to act by written consent. Shareholder proposalAgainstFor
May 14, 2026CBOE GLOBAL MARKETS, INC.Stockholder proposal regarding shareholder right to act by written consent. Shareholder proposalAgainstFor

Search this fund’s votes by company

741 ballot items at 84 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Guardian Small-Mid Cap Core VIP Fund voted at 84 shareholder meetings of 84 companies, on 741 ballot items in all. Where management made a recommendation, the fund followed it on 97.8% of the items and voted against it 4 times. Its most frequent area of disagreement was corporate governance (2 of its votes against management). It voted on 5 shareholder proposals. It voted FOR the board's own proposals less often than Guardian Variable Products Trust's funds as a whole (93.4% against 95.0%). It voted differently from most Guardian Variable Products Trust funds on 2 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Guardian Variable Products Trust’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.